Back to News
Market Impact: 0.25
Cytosorbents To Implement 1-For-20 Reverse Stock Split, Stock Down In Pre-Market
Source: Nasdaq
Company FundamentalsManagement & Governance
Cytosorbents (CTSO) announced a one-for-twenty reverse stock split of its common shares, effective September 8, 2026. The move is typically associated with maintaining listing compliance and can be viewed as a near-term negative signal for equity sentiment, though no financial guidance or earnings figures were provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.30
Ticker Sentiment
CTSO-0.25
More News
- Nvidia CEO Jensen Huang emerges as Trump's top ally in AI safety debate
- Williams-Sonoma's stock has soared in a sluggish housing market. Here's how it won over Wall Street
- Jensen Huang Just Announced Fantastic News for Nvidia Shareholders
- U.S.-China gastrodiplomacy: Despite political tension, fast food chains from both countries gain popularity in each other’s territory
- Buying This Hidden Software Stock Might Just Give You Massive Exposure to the Anthropic IPO
- Budget airline king Bill Franke warms to first-class seats and premium upgrades